北京市嘉源律师事务所 关于联化科技股份有限公司 2025年第一次临时股东大会的 法律意见书 西城区复兴门内大街 158 号远洋大厦 4 楼 中国·北京 北京市嘉源律师事务所 北京BEIJING·上海SHANGHAI·深圳SHENZHEN·香港HONG KONG·广州GUANGZHOU·西安XI'AN 致：联化科技股份有限公司 关于联化科技股份有限公司 2025年第一次临时股东大会的 法律意见书 嘉源(2025)-04-683 北京市嘉源律师事务所（以下简称"本所"）接受联化科技股份有限公司（以 下简称"公司"）的委托，根据《中华人民共和国公司法》（以下简称"《公司 法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公 司股东会规则》（以下简称"《股东会规则》"）等现行有效的法律、行政法规、 部门规章、规范性文件（以下简称"法律法规"）以及《联化科技股份有限公司 章程》（以下简称"《公司章程》"）的有关规定，指派本所律师对公司2025 年第一次临时股东大会（以下简称"本次股东大会"）进行见证，并依法出具本 法律意见书。 为出具本法律意见书，本所指派律师现场见证了本次股东大会，查阅了公司 提供的 ...

第九届董事会第一次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 联化科技股份有限公司（以下简称"公司"）第九届董事会第一次会议通知 于2025年9月11日以电子邮件方式通知各董事（包括董事候选人）。会议于2025 年9月16日在联化科技会议室以现场与通讯表决相结合的方式召开。会议应出席 董事7人，实际出席董事7人。公司高级管理人员列席了本次会议，与会董事一致 推荐王萍女士主持会议，符合《公司法》、《证券法》等法律法规、部门规章、规 范性文件及《公司章程》的有关规定。会议形成如下决议： 一、会议以7票同意，0票反对，0票弃权的表决结果，审议并通过了《关于 选举董事长的议案》。 与会董事一致选举王萍女士为公司第九届董事会董事长，其任期自本次董事 会审议通过之日起至第九届董事会届满为止。 二、会议以7票同意，0票反对，0票弃权的表决结果，审议并通过了《关于 选举代表公司执行公司事务董事的议案》。 与会董事一致选举王萍女士为公司第九届董事会代表公司执行公司事务董 事，其任期自本次董事会审议通过之日起至第九届董事会届满为止。 三、会议以7票同意，0票反对 ...

Company Overview - Lianhua Technology Co., Ltd. is located in Taizhou, Zhejiang Province, established on September 14, 1998, and listed on June 19, 2008 [2] - The company operates in three main business segments: pesticides, pharmaceuticals, and functional chemicals, with revenue contributions of 54.03%, 32.32%, 8.42%, and 4.88% from equipment and engineering services, respectively [2] - As of June 30, 2025, the number of shareholders increased by 88.92% to 72,300, while the average circulating shares per person decreased by 47.07% to 12,533 shares [2] Financial Performance - For the first half of 2025, Lianhua Technology achieved a revenue of 3.15 billion yuan, representing a year-on-year growth of 5.76%, and a net profit attributable to shareholders of 224 million yuan, a significant increase of 1481.94% [2] - The company has distributed a total of 960 million yuan in dividends since its A-share listing, with 129 million yuan distributed over the past three years [3] Stock Market Activity - On September 16, Lianhua Technology's stock price fell by 2.03% to 11.12 yuan per share, with a trading volume of 182 million yuan and a turnover rate of 1.79%, resulting in a total market capitalization of 10.134 billion yuan [1] - Year-to-date, the stock price has increased by 102.55%, but it has seen a decline of 1.77% over the last five trading days and a drop of 17.38% over the past 60 days [1] - The company has appeared on the "Dragon and Tiger List" nine times this year, with the most recent appearance on June 25, where it recorded a net buy of -46.854 million yuan [1]

证券日报网讯联化科技（002250）9月15日在互动平台回答投资者提问时表示，公司与国内、国际市场 领先厂商形成战略合作，结合自有的技术特长和生产资源，为客户提供差异化、定制化的产品服务，与 客户共同成长，开发和提供了多种具有竞争力的关键化学品。 ...

Core Viewpoint - The company is actively focusing on the development of cutting-edge products in the new energy sector, aligning with customer demands and optimizing its services and technology to reduce costs and promote innovation [1] Group 1 - The company is responding to customer needs in its new energy business [1] - The company is committed to product planning and service optimization [1] - The company aims to lower costs and foster innovation for future growth [1]

Core Viewpoint - The company, Lianhua Technology (002250), is focusing on its pharmaceutical business primarily through a CDMO (Contract Development and Manufacturing Organization) model and aims to actively expand its business to ensure continuous development [1] Summary by Relevant Sections - **Company Business Model** - The pharmaceutical business of the company is mainly based on the CDMO model [1] - **Business Development Strategy** - The company will actively engage in business development efforts to promote sustained growth [1]

Company Overview - Lianhua Technology Co., Ltd. is located in Taizhou, Zhejiang Province, established on September 14, 1998, and listed on June 19, 2008 [2] - The company operates in three main sectors: pesticides, pharmaceuticals, and functional chemicals, with revenue contributions of 54.03%, 32.32%, 8.42%, and 4.88% from equipment and engineering services, respectively [2] - As of June 30, the number of shareholders increased to 72,300, with an average of 12,533 circulating shares per person, a decrease of 47.07% [2] Financial Performance - For the first half of 2025, Lianhua Technology achieved revenue of 3.15 billion yuan, a year-on-year increase of 5.76%, and a net profit attributable to shareholders of 224 million yuan, a significant increase of 1481.94% [2] - The company has distributed a total of 960 million yuan in dividends since its A-share listing, with 129 million yuan distributed in the last three years [3] Stock Performance - On September 15, Lianhua Technology's stock price rose by 2.13% to 11.52 yuan per share, with a trading volume of 407 million yuan and a turnover rate of 3.98%, bringing the total market capitalization to 10.499 billion yuan [1] - The stock has increased by 109.84% year-to-date, with a slight increase of 0.44% over the last five trading days and a 12.94% increase over the last 20 days, while it has decreased by 10.90% over the last 60 days [1] - The company has appeared on the trading leaderboard nine times this year, with the most recent appearance on June 25, where it recorded a net buy of -46.85 million yuan [1] Shareholding Structure - As of June 30, the second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 40.3583 million shares, an increase of 21.3384 million shares from the previous period [3] - The fund "Noan Pioneer Mixed A" has exited the list of the top ten circulating shareholders [3]

Group 1 - The company is experiencing a gradual recovery in its plant protection business [2] - An investor inquired about the sufficiency of the company's plant protection business orders for the second half of the year [2] - The company responded positively regarding the current state of its plant protection business [2]

Group 1 - The company has a planned production capacity of LiFSI (lithium bis(fluorosulfonyl)imide) for new energy batteries at 10,000 tons per year [2] - Currently, the company supplies LiFSI in liquid form [2]

Core Viewpoint - The company has outlined its production capacity plans for lithium bis(fluorosulfonyl)imide (LiFSI) and cathode materials for new energy batteries, indicating a planned capacity of 10,000 tons per year for LiFSI [2]. Group 1 - The company responded to an investor inquiry regarding the production capacity of LiFSI, stating it is planned at 10,000 tons per year [2]. - The cathode materials are described as customized processing products, with specific production data not disclosed [2].